Apellis Pharmaceuticals
APLS
$39.25
Share price
-3.68%
Change (1 day)
-55.05%
Change (1 year)
Categories
P/S ratio for Apellis Pharmaceuticals (APLS)
P/S ratio as of June 2024 (TTM): 9.52
According to Apellis Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.52039. At the end of 2023 the company had a P/S ratio of 17.9.
P/S ratio history for Apellis Pharmaceuticals from 2017 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 17.9 | -76.41% |
| 2022 | 75.8 | 9.63% |
| 2021 | 69.2 | 300.1% |
| 2020 | 17.3 | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |